Coronavirus / COVID

My hope is that years from now, when we look back on the coronavirus disease 2019 (COVID-19) pandemic, it will have served a few purposes.

The only new drug approved for COVID-19 treatment has limited efficacy, but is still desperately needed to fight pandemic.

Adam Brufsky, MD, PhD, addresses the potential for changing dynamics in SARS-CoV-2.

An assessment observing 4 states under stay-at-home orders showed all avoided worsened outcomes of severe infection rates.

Clinicians and researchers have questioned the likelihood of assembling the quantity of data supplied by Surgisphere on hydroxychloroquine in such a short period of time.

A brief on the latest infectious disease headlines.

Matthew F. Pullen, MD, co-author of the recent hydroxychloroquine prophylaxis trial, shares the top clinical takeaways.

The test measures IL-6 to identify patients with COVID-19 at high risk of intubation.

About two-thirds of patients that reported loss of smell associated with viral infection actually had confirmed anosmia after objective olfactory testing.

Though most trace the coronavirus outbreak to China, a new analysis finds most of the cases in New York seem to have originated in Europe.

The trial consisted of non-hospitalized adults who indicated a high-risk or moderate-risk exposure to COVID-19 through the household or an occupational setting.

Why people may need to readjust their expectations around COVID-19 clinical data and drugs.

John Strotbeck, Olympian and CEO of Boathouse Sports, explains how and why the outerwear company pivoted to PPE production at the start of the COVID-19 pandemic.

A review of the latest infectious disease news.

An eventual COVID-19 vaccination should be prepared to face obstacles before distribution, so the groundwork for factual information dissemination should begin now.

Sarah Jorgensen, PharmD, MPH, BCPS, BCIDP, AAHIVP, provides a deep dive on the pharmacology and biochemistry of remdesivir.

While COVID-19 may have impacted flu-like illness reporting, the CDC estimates there were between 24,000-62,000 related deaths this year.

A study team investigated the ideal physical distance for avoiding SARS-CoV-2 transmission and assessed the use of eye protection and face coverings in preventing acquisition.

Denise Bascow, MD, describes a platform for keeping up to date with the latest clinical information.

A look at the means by which clinicians are quantifying and evaluating the effects of the antiviral drug.

New findings from the CDC show community transmission may have begun in the Pacific Northwest a full month before the first confirmed case.

It's been one month since the antiviral therapy was granted emergency use authorization. How has it affected COVID-19 care?

The COVID-19 pandemic has put the brakes on HIV cure research, but investigators report recent progress and promising pathways nonetheless.

A daily infectious disease news update

Investigators sought to summarize evidence about the benefits and harms of hydroxychloroquine and chloroquine as treatments or prophylaxis of COVID-19.